FMP

FMP

Enter

MRKR - Marker Therapeutics,...

photo-url-https://images.financialmodelingprep.com/symbol/MRKR.png

Marker Therapeutics, Inc.

MRKR

NASDAQ

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.

1.1 USD

-0.1 (-9.09%)

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

21.35M

42.35M

11.78M

15.11M

19.19T

10.49T

16.7T

26.59T

42.33T

67.39T

Total Cash %

4.57k

3.41k

130.85

456.38

291.19

100

100

100

100

Receivables

1M

237

2.4M

1.03M

2.35T

4.06T

6.46T

10.28T

16.37T

26.06T

Receivables %

214.35

0.02

26.68

31.04

35.6

38.67

38.67

38.67

38.67

Inventories

-1M

-

-

-988.13k

-

-2.72T

-4.34T

-6.91T

-10.99T

-17.5T

Inventories %

-214.23

-

-

-29.84

-

-25.97

-25.97

-25.97

-25.97

Payable

2.94M

5.14M

1.1M

961k

-

5.06T

8.06T

12.83T

20.42T

32.51T

Payable %

628.77

414.27

12.23

29.02

-

48.25

48.25

48.25

48.25

Cap Ex

-10.43M

-3.13M

-4.95M

-

-

-5.35T

-8.52T

-13.56T

-21.58T

-34.36T

Cap Ex %

-2.23k

-252.16

-54.92

-

-

-50.98

-50.98

-50.98

-50.98

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep